Greater utility of molecular subtype rather than epithelial‐to‐mesenchymal transition (EMT) markers for prognosis in high‐risk non‐muscle‐invasive (HGT1) bladder cancer

by Edward C Ottley, Robert Pell, Benedict Brazier, Julianne Hollidge, Christiana Kartsonaki, Lisa Browning, Eric O'Neill, Anne E Kiltie
Published 2020-10-01